Kevin M. Shannon
Affiliations: | Biomedical Sciences | University of California, San Francisco, San Francisco, CA |
Area:
Cell Biology, Molecular BiologyGoogle:
"Kevin Shannon"Children
Sign in to add trainee| Suzanne Schubbert | grad student | 2007 | UCSF |
| Abigail L. Miller | grad student | 2011 | UCSF |
| Kegan L. Donlan | grad student | 2013 | UCSF |
| N. Monique Dail | post-doc | 2006-2014 | UCSF (Chemistry Tree) |
| Ari J. Firestone | post-doc | 2012-2015 | UCSF (Chemistry Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| D'Souza J, Leung CJ, Ballapuram AC, et al. (2025) Inactivation Confers Resistance to the Menin Inhibitor Revumenib in Acute Myeloid Leukemia. Biorxiv : the Preprint Server For Biology |
| Decker M, Huang BJ, Ware T, et al. (2025) validation of the palmitoylation cycle as a therapeutic target in -mutant cancer. Biorxiv : the Preprint Server For Biology |
| Zhang JZ, Li X, Batingana AR, et al. (2025) design of Ras isoform selective binders. Biorxiv : the Preprint Server For Biology |
| Levinson A, Shannon K, Huang BJ. (2024) Targeting Hyperactive Ras Signaling in Pediatric Cancer. Cold Spring Harbor Perspectives in Medicine |
| Chen PY, Huang BJ, Harris M, et al. (2023) Structural and functional analyses of a germline KRAS T50I mutation provide insights into Raf activation. Jci Insight. 8 |
| Suciu RM, Luvaga IK, Hazeen A, et al. (2021) Chemical proteomic analysis of palmostatin beta-lactone analogs that affect N-Ras palmitoylation. Bioorganic & Medicinal Chemistry Letters. 128414 |
| Remsberg JR, Suciu RM, Zambetti NA, et al. (2021) ABHD17 regulation of plasma membrane palmitoylation and N-Ras-dependent cancer growth. Nature Chemical Biology |
| Wong JC, Perez-Mancera PA, Huang TQ, et al. (2020) KrasP34R and KrasT58I mutations induce distinct RASopathy phenotypes in mice. Jci Insight |
| Pucciarelli D, Angus SP, Huang B, et al. (2020) Nf1 mutant tumors undergo transcriptome and kinome re-modeling after inhibition of either mTOR or MEK. Molecular Cancer Therapeutics |
| Zambetti NA, Firestone AJ, Remsberg JR, et al. (2020) Genetic disruption of N-RasG12D palmitoylation perturbs hematopoiesis and prevents myeloid transformation in mice. Blood |